Healthcare / Medical Care FacilitiesUpdated 2026-05-10 22:07 UTC

HKG/1830 stock hub

HKG/1830 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

HKG/1830is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.5B

Hong Kong Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

HKG/1830

In the news

Latest news · HKG/1830

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 11.7P50 18.9P75 41.4

Trailing P/E9.5

P25 10.7P50 17.9P75 38.5

ROE38.3

P25 -14.7P50 2P75 9.4

ROIC89.3

P25 -10.4P50 1.9P75 10.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All HKG/1830 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

236

Groups with data

Currency

HKD

Showing 236 of 236 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Cayman Islands
Country code	HK
Employees	840
Employees Change	-131%
Employees Change Percent	-13.49
Enterprise value	HKD 1.3B
Exchange	Hong Kong Stock Exchange
Financial currency	HKD
First seen	2026-05-10
Industry	Medical Care Facilities
Isin	KYG7013H1056
Last refreshed	2026-05-10
Market cap	HKD 1.5B
Price	HKD 1.21
Price currency	HKD
Rev Per Employee	1,182,703.57x
Sector	Healthcare
Sic	7200
Symbol	hkg/1830
Website	https://perfectmedical.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	10.58%
EV Earnings	7.93x
EV/EBIT	6.35x
EV/EBITDA	3.44x
EV/FCF	5.08x
EV/Sales	1.28x
FCF yield	16.51%
P/B ratio	3.59x
P/E ratio	9.45x
P/S ratio	1.53x
PE Ratio10 Y	16.23x
PE Ratio3 Y	11.55x
PE Ratio5 Y	12.42x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	20.2%
EBITDA Margin	26.56%
FCF margin	25.27%
Gross margin	62.48%
Gross Profit	HKD 620.7M
Gross Profit Growth	-11.48%
Gross Profit Growth Q	-20.52%
Gross Profit Growth3 Y	-11.46%
Gross Profit Growth5 Y	-6.87%
Net Income	HKD 160.9M
Net Income Growth	-44.58%
Net Income Growth Q	-32.69%
Net Income Growth Years	0%
Net Income Growth3 Y	-20.14%
Net Income Growth5 Y	-12.61%
Pretax Margin	20.44%
Profit Margin	16.19%
Profit Per Employee	HKD 191,494
Profitable Years	15
ROA	12.53
Roa5y	16.38
ROCE	35.18
ROE	38.33
Roe5y	50.74
ROIC	89.28
Roic5y	100.5

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	14.73%
Cagr1y	-39.44%
Cagr3y	-24.75%
Cagr5y	-22.02%
Div CAGR10	0.48%
Div CAGR3	-13.74%
Div CAGR5	-22.79%
EPS Growth	-44.59
EPS Growth Q	-33.04
EPS Growth Years	0
EPS Growth3 Y	-20.11
EPS Growth5 Y	-12.72
FCF Growth	-29.13%
FCF Growth Q	-23.21%
FCF Growth3 Y	-16.99%
FCF Growth5 Y	-13.93%
OCF Growth	-30.74%
OCF Growth Q	-23.21%
OCF Growth10 Y	-7.13%
OCF Growth3 Y	-16.86%
OCF Growth5 Y	-12.61%
Revenue Growth	-23.31x
Revenue Growth Q	-21.67x
Revenue Growth Years	0x
Revenue Growth3 Y	-10.66x
Revenue Growth5 Y	-6.49x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	HKD 0.99
Assets	HKD 925.4M
Cash	HKD 417M
Current Assets	HKD 508.3M
Current Liabilities	HKD 355M
Debt	HKD 177.1M
Debt EBITDA	HKD 0.48
Debt Equity	HKD 0.42
Debt FCF	HKD 0.71
Equity	HKD 423.5M
Interest Coverage	20.77
Liabilities	HKD 501.9M
Long Term Assets	HKD 417.1M
Long Term Liabilities	HKD 146.9M
Net Cash	HKD 239.9M
Net Cash By Market Cap	HKD 15.78
Net Cash Growth	3.09%
Net Debt EBITDA	HKD -0.91
Net Debt Equity	HKD -0.57
Net Debt FCF	HKD -0.96
Tangible Book Value	HKD 428.7M
Tangible Book Value Per Share	HKD 0.34
WACC	8.01

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.43
Inventory Turnover	27.49
Net Working Capital	HKD -188.6M
Quick ratio	1.37
Working Capital	HKD 153.2M
Working Capital Turnover	HKD 7.51

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend Growth	-54.9%
Dividend Growth Years	0%
Dividend per share	HKD 0.13
Dividend Years	14
Dividend Yield	10.66%
Ex Div Date	2025-12-12
Last Dividend	HKD 0.08
Payout Frequency	Semi-Annual
Payout Ratio	223.35%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	294.98%
1Y total return	-39.42%
200-day SMA	1.36
3Y total return	-57.39%
50-day SMA	1.18
50-day SMA vs 200-day SMA	50under200
5Y total return	-71.15%
All Time High	10.9
All Time High Change	-88.9%
All Time High Date	2021-07-07
All Time Low	0.1
All Time Low Change	1,059%
All Time Low Date	2012-06-08
ATR	0.04
Beta	0.76
Beta1y	0.55
Beta2y	0.32
Ch YTD	-2.42
High	1.23
High52	2.4
High52 Date	2025-06-12
High52ch	-49.58%
Low	1.2
Low52	1.11
Low52 Date	2026-04-02
Low52ch	9.01%
Ma50ch	2.54%
Price vs 200-day SMA	-11.09%
RSI	55.05
RSI Monthly	31.09
RSI Weekly	40.25
Sharpe ratio	-1.52x
Sortino ratio	-1.66
Total Return	10.66%
Tr YTD	-2.42
Tr1m	7.08%
Tr1w	1.68%
Tr3m	-1.63%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	HKD 200.6M
Operating Income Growth	-19.04
Operating Income Growth Q	-30.2
Operating Income Growth3 Y	-18.86
Operating Income Growth5 Y	-11.46
Operating margin	20.2

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	314,054,003%
Net Borrowing	-109,552,000
Shares Insiders	9.15%
Shares Institutions	0.46%
Shares Out	1,256,197,771
Shares Qo Q	0%
Shares Yo Y	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	HKD 247.6M
Average Volume	360,119.55x
Bv Per Share	0.34
CAPEX	HKD -34.7M
Ch10y	37.5
Ch1m	7.08
Ch1w	1.68
Ch1y	-44.5
Ch3m	-1.63
Ch3y	-68.07
Ch5y	-80.79
Ch6m	-12.32
Change	0%
Change From Open	0
Close	1.21
Days Gap	0
Depreciation Amortization	63,220,000
Dollar Volume	338,941.6
Earnings Date	2026-06-26
EBIT	HKD 200.6M
EBITDA	HKD 263.9M
EPS	HKD 0.13
F Score	6
FCF	HKD 251M
FCF EV Yield	19.69x
FCF Per Share	HKD 0.2
Financing CF	-327,739,000
Fiscal Year End	March
Founded	2,003
Graham Number	0.98552
Graham Upside	-18.55
Income Tax	HKD 37.2M
Investing CF	82,643,000
Is Primary Listing	1
Last Earnings Date	2026-02-27
Last Report Date	2025-09-30
Lynch Fair Value	HKD 0.64
Lynch Upside	-47.09
Ma150	1.28
Ma150ch	-5.69%
Ma20	1.19
Ma20ch	1.42%
Net CF	36,199,000
Next Earnings Date	2026-06-26
Open	1.21
P FCF Ratio	6.06
P OCF Ratio	5.32
Payment Date	2025-12-31
Position In Range	33.33
Ppne	261,410,000
Price Date	2026-05-08
Price EBITDA	HKD 5.76
Ptbv Ratio	3.55
Relative Volume	0.8x
Revenue	993,471,000x
SBC By Revenue	0.35x
Share Based Comp	3,444,000
Tax By Revenue	3.75x
Tax Rate	18.32%
Tr6m	-7.4%
Volume	280,117
Z Score	5.38

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

HKG/1830 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+10.7%

$0.13 annual per share

Payout ratio

+223.4%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

-22.8%

0 consecutive years of growth

Total shareholder yield

+10.7%

Next ex-dividend date: 2025-12-12

Performance

HKG/1830 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns HKG/1830?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.5%

Share of float held by funds and institutions

Insider ownership

+9.2%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

0.0%

Negative means the company is buying back shares.

Technical

HKG/1830 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

55.0

Neutral momentum band

Price vs 200-day MA

-11.1%

50/200-day relationship not available

Beta (5Y)

0.76

Less volatile than the market

Sharpe ratio

-1.52

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About HKG/1830

Hub-level FAQ points readers to the deeper analysis pages.

What is the current hkg/1830 stock rating?

hkg/1830 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full hkg/1830 analysis?

The full report lives at /stocks/hkg/1830/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for hkg/1830?

The latest report frames hkg/1830 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the hkg/1830 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.